World’s First Integrated Imaging Service for Long Covid approved by UK’s MHRA. Read more.
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS)
![]() |
Summary Identification and validation of biomarkers for non-alcoholic steatohepatitis (NASH) and across the spectrum of non-alcoholic fatty liver disease (NAFLD). |
![]() |
Disease Area Liver Disease |
![]() |
Product LiverMultiScan® |
![]() |
Status Open for Recruitment |
![]() |
Country Multiple European |
![]() |
Website |